Skip to main content
españolES
European Commission logo print header

A patient-centered early risk prediction, prevention, and intervention platform to support the continuum of care in coronary artery disease (CAD) using eHealth and artificial intelligence

Descripción del proyecto

DEENESFRITPL

Aplicaciones basadas en inteligencia artificial para un corazón sano

Durante los últimos 25 años, el total absoluto de casos de enfermedades cardiovasculares (ECV) ha aumentado en Europa. En la actualidad, las ECV causan 3,9 millones de muertes en Europa cada año y representan el 45 % del total de muertes. Dado que la arteriopatía coronaria se desarrolla lentamente, generalmente a lo largo de decenios, es importante mejorar la predicción del riesgo individual de progresión de la enfermedad. El proyecto financiado con fondos europeos TIMELY desarrollará una plataforma para ofrecer aplicaciones y paneles basados en inteligencia artificial, así como herramientas de apoyo a la toma de decisiones, con el fin de ayudar a los pacientes y al personal clínico a personalizar la atención sanitaria a partir de la evaluación del riesgo. Basándose en una plataforma funcional e interoperable, el proyecto simplificará el intercambio de datos y supervisará y evaluará los riesgos de forma continua.

Objetivo

Coronary artery disease (CAD) remains the leading cause of disease burden globally. CAD develops slowly, usually over decades, and depends on multiple (often modifiable) risk factors and their interactions. Self-management and patient activation are of rising importance as current restrictions in healthcare budgets impose great difficulties to enable the provision of qualitative secondary prevention to all cardiac patients in an era facing a huge cardiovascular disease epidemic.
The main hypothesis in the patient-centered TIMELY pathway, is that a modular, collaborative eHealth platform, supported by Artificial Intelligence (AI) for the continuous and in-time prediction of cardiac risks and complications and the induction of targeted behavioural change interventions, can be effective and cost-efficient for the secondary prevention of CAD by limiting the physiological and psychological effects of the disease and improving risk factor and symptom management. Improvements in patients’ self-care and empowerment and clinicians’ efficiency are also expected.
Along the continuum of the disease, prediction of the individual risk for disease progression, including physical impairment and severe events, is mandatory for timely intervention. TIMELY is a platform that provides AI-powered apps and dashboards and decision support tools assisting patients and clinicians to personalize healthcare based on risk evaluation, outcome prediction and tailored interventions. The platform will be developed based on a functional platform for Interoperability with electronic health records and security mechanisms, to ensure information completeness and continuity and to simplify data sharing. AI in TIMELY, built with big retrospective datasets of >23.000 CAD patients, will constantly monitor and evaluate risks and will indicate any deviation from defined therapy goals or unfavorable changes as well as propose proper interventions.

Ámbito científico

Palabras clave

Programa(s)

Tema(s)

Convocatoria de propuestas

H2020-SC1-DTH-2018-2020

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-SC1-DTH-2020-1

Régimen de financiación

RIA - Research and Innovation action

Coordinador

UNIVERSITEIT VAN AMSTERDAM
Aportación neta de la UEn
€ 845 442,50
Dirección
SPUI 21
1012WX Amsterdam
Países Bajos

Ver en el mapa
Región
West-Nederland Noord-Holland Groot-Amsterdam
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 845 442,50

Participantes (16)

Compartir esta página

Descargar

Última actualización: 22 Abril 2024

Mi folleto

Permalink: https://cordis.europa.eu/project/id/101017424/es

European Union, 2024